Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

435 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma.
Skakkebaek NE, Berthelsen JG, Giwercman A, Müller J. Skakkebaek NE, et al. Int J Androl. 1987 Feb;10(1):19-28. doi: 10.1111/j.1365-2605.1987.tb00161.x. Int J Androl. 1987. PMID: 3034791
As a consequence of these hypotheses an alternative nomenclature for carcinoma-in-situ, seminoma and dysgerminoma is suggested....
As a consequence of these hypotheses an alternative nomenclature for carcinoma-in-situ, seminoma and dysgerminoma is suggested....
The human testis--an organ at risk?
Giwercman A, Skakkebaek NE. Giwercman A, et al. Int J Androl. 1992 Oct;15(5):373-5. doi: 10.1111/j.1365-2605.1992.tb01351.x. Int J Androl. 1992. PMID: 1428195 No abstract available.
Localized irradiation of testes with carcinoma in situ: effects on Leydig cell function and eradication of malignant germ cells in 20 patients.
Giwercman A, von der Maase H, Berthelsen JG, Rørth M, Bertelsen A, Skakkebaek NE. Giwercman A, et al. J Clin Endocrinol Metab. 1991 Sep;73(3):596-603. doi: 10.1210/jcem-73-3-596. J Clin Endocrinol Metab. 1991. PMID: 1908483
Follow-up testicular biopsies performed 3 (n = 19) and 24 (n = 14) months after the treatment showed in all cases a Sertoli cell-only pattern. ...Development of a second testicular cancer has until now been prevented. Leydig cell function was partially impaired by t …
Follow-up testicular biopsies performed 3 (n = 19) and 24 (n = 14) months after the treatment showed in all cases a Sertoli cell-only …
Clinical and biological significance of carcinoma in situ of the testis.
Jørgensen N, Müller J, Giwercman A, Skakkebaek NE. Jørgensen N, et al. Cancer Surv. 1990;9(2):287-302. Cancer Surv. 1990. PMID: 1964624 Review.
Carcinoma in situ (CIS) of the testis is a preinvasive lesion that with time progresses into invasive germ cell tumour. CIS precedes all types of germ cell tumours except spermatocytic seminoma. ...We recommend orchidectomy as the treatment of choice in cases of unilateral …
Carcinoma in situ (CIS) of the testis is a preinvasive lesion that with time progresses into invasive germ cell tumour. CIS precedes …
Carcinoma in situ of the testis. Detection of malignant germ cells in seminal fluid by means of in situ hybridization.
Giwercman A, Hopman AH, Ramaekers FC, Skakkebaek NE. Giwercman A, et al. Am J Pathol. 1990 Mar;136(3):497-502. Am J Pathol. 1990. PMID: 2316622 Free PMC article.
We developed a noninvasive procedure for detection of CIS of the testis by means of a nonradioactive in situ hybridization assay with a probe for chromosome 1. ...In a blind study we identified samples from both patients with isolated CIS changes and f …
We developed a noninvasive procedure for detection of CIS of the testis by means of a nonradioactive in situ hybridization ass …
Monoclonal antibody 43-9F as a sensitive immunohistochemical marker of carcinoma in situ of human testis.
Giwercman A, Lindenberg S, Kimber SJ, Andersson T, Müller J, Skakkebaek NE. Giwercman A, et al. Cancer. 1990 Mar 1;65(5):1135-42. doi: 10.1002/1097-0142(19900301)65:5<1135::aid-cncr2820650517>3.0.co;2-t. Cancer. 1990. PMID: 2406007
Thus, the monoclonal antibody 43-9F is a sensitive immunohistochemical marker of CIS germ cells and may also be of potential value in detection of invasive testicular cancer....
Thus, the monoclonal antibody 43-9F is a sensitive immunohistochemical marker of CIS germ cells and may also be of potential value in …
Management of carcinoma-in-situ of the testis.
von der Maase H, Giwercman A, Müller J, Skakkebaek NE. von der Maase H, et al. Int J Androl. 1987 Feb;10(1):209-20. doi: 10.1111/j.1365-2605.1987.tb00186.x. Int J Androl. 1987. PMID: 2438219
A monoclonal antibody as a marker for carcinoma in situ germ cells of the human adult testis.
Giwercman A, Marks A, Bailey D, Baumal R, Skakkebaek NE. Giwercman A, et al. APMIS. 1988 Aug;96(8):667-70. doi: 10.1111/j.1699-0463.1988.tb00927.x. APMIS. 1988. PMID: 2843208
Carcinoma in situ of the testis (CIS) is a precursor of invasive testicular germ cell tumours. The diagnosis of CIS is however often missed when conventional histological techniques are used. ...Thus, M2A may serve as a diagnostic marker in detection of CIS germ cel …
Carcinoma in situ of the testis (CIS) is a precursor of invasive testicular germ cell tumours. The diagnosis of CIS is however often …
Radiation treatment of carcinoma-in-situ of testis.
von der Maase H, Giwercman A, Skakkebaek NE. von der Maase H, et al. Lancet. 1986 Mar 15;1(8481):624-5. doi: 10.1016/s0140-6736(86)92853-9. Lancet. 1986. PMID: 2869338 No abstract available.
435 results
Jump to page
Feedback